JP2022521722A - 呼吸器薬剤デバイスの使用を改善するためのシステムおよび方法 - Google Patents
呼吸器薬剤デバイスの使用を改善するためのシステムおよび方法 Download PDFInfo
- Publication number
- JP2022521722A JP2022521722A JP2021547876A JP2021547876A JP2022521722A JP 2022521722 A JP2022521722 A JP 2022521722A JP 2021547876 A JP2021547876 A JP 2021547876A JP 2021547876 A JP2021547876 A JP 2021547876A JP 2022521722 A JP2022521722 A JP 2022521722A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- respiratory
- data
- patient
- sensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 title claims abstract description 429
- 239000003814 drug Substances 0.000 title claims abstract description 429
- 230000000241 respiratory effect Effects 0.000 title claims abstract description 108
- 238000000034 method Methods 0.000 title claims abstract description 102
- 208000023504 respiratory system disease Diseases 0.000 claims abstract description 51
- 238000005516 engineering process Methods 0.000 claims description 38
- 238000003860 storage Methods 0.000 claims description 30
- 230000036541 health Effects 0.000 claims description 21
- 238000004891 communication Methods 0.000 claims description 19
- 230000004044 response Effects 0.000 claims description 16
- 230000000007 visual effect Effects 0.000 claims description 15
- 238000007405 data analysis Methods 0.000 claims description 10
- 230000003111 delayed effect Effects 0.000 claims description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 abstract description 12
- 238000004458 analytical method Methods 0.000 description 74
- 208000006673 asthma Diseases 0.000 description 57
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 31
- 238000012552 review Methods 0.000 description 14
- 238000007726 management method Methods 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 230000004913 activation Effects 0.000 description 10
- 238000001994 activation Methods 0.000 description 10
- 229940112141 dry powder inhaler Drugs 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 238000001647 drug administration Methods 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 230000003442 weekly effect Effects 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- 230000009897 systematic effect Effects 0.000 description 7
- 238000012549 training Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000002483 medication Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000001960 triggered effect Effects 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940125369 inhaled corticosteroids Drugs 0.000 description 4
- 229940127558 rescue medication Drugs 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000014085 Chronic respiratory disease Diseases 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940071648 metered dose inhaler Drugs 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000001755 vocal effect Effects 0.000 description 3
- PZSMUPGANZGPBF-UHFFFAOYSA-N 4-[5-(dithiolan-3-yl)pentanoylamino]butanoic acid Chemical compound OC(=O)CCCNC(=O)CCCCC1CCSS1 PZSMUPGANZGPBF-UHFFFAOYSA-N 0.000 description 2
- PJFHZKIDENOSJB-UHFFFAOYSA-N Budesonide/formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1.C1CC2=CC(=O)C=CC2(C)C2C1C1CC3OC(CCC)OC3(C(=O)CO)C1(C)CC2O PJFHZKIDENOSJB-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 229940125389 long-acting beta agonist Drugs 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000000422 nocturnal effect Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940035073 symbicort Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- 208000037874 Asthma exacerbation Diseases 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001138637 Durella Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229940125388 beta agonist Drugs 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- -1 levalvterol Chemical compound 0.000 description 1
- 229940125386 long-acting bronchodilator Drugs 0.000 description 1
- 230000005980 lung dysfunction Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
- 230000001459 mortal effect Effects 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000015047 pilsener Nutrition 0.000 description 1
- 238000013439 planning Methods 0.000 description 1
- 229940012484 proair Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940063566 proventil Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4833—Assessment of subject's compliance to treatment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0266—Operational features for monitoring or limiting apparatus function
- A61B2560/028—Arrangements to prevent overuse, e.g. by counting the number of uses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
- A61B5/067—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe using accelerometers or gyroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
- A61B5/068—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe using impedance sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
- A61J7/0436—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system resulting from removing a drug from, or opening, a container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0481—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers working on a schedule basis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
- A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/27—General characteristics of the apparatus preventing use
- A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/332—Force measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/587—Lighting arrangements
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Physiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims (34)
- 呼吸器疾患に対する呼吸器薬剤デバイスの使用技術を決定するためのシステムであって、
患者の薬剤計画に関連する薬剤データを収集し、前記患者へコントローラまたはレスキュー呼吸薬剤を送出する呼吸器薬剤デバイスの使用データを収集する通信インターフェイスと、
前記収集された薬剤データを格納し、前記収集された使用データを格納する記憶デバイスと、
前記収集された薬剤データに基づいて、薬剤デバイスのタイプが前記呼吸器薬剤デバイスの複数の連続する使用を必要とするかどうかを識別し、
前記収集された使用データに基づいて、前記呼吸器薬剤デバイスの連続する使用の間のタイミングを決定し、
前記呼吸器薬剤デバイスの連続する使用の間の前記タイミングに基づいて、適切または不適切な使用技術として前記連続する使用を分類し、使用技術の記録を生成し、
前記使用技術の記録に基づく適切または不適切な使用技術の少なくとも1つの通知を提供し、適切な使用技術を確実にする、
ように動作可能なデータ分析モジュールと、
を備えた、システム。 - 前記収集された薬剤データは、薬剤タイプ、薬剤デバイスタイプ、および所定の服用回数の少なくとも1つに関する情報を含む、請求項1に記載のシステム。
- 前記収集された薬剤データは複数の薬剤タイプまたは薬剤デバイスタイプの連続する服用の間に必要な時間期間に関する情報を含む、請求項1または請求項2に記載のシステム。
- 前記複数の連続する使用は前記呼吸器薬剤デバイスの2回の連続する使用であり、前記2回の使用は、120秒以下で時間的に分離されている、請求項1から請求項3のいずれかに記載のシステム。
- 適切な使用技術は前記呼吸器薬剤デバイスの連続する使用の間の30秒を超える時間期間を含む、請求項1から請求項4のいずれかに記載のシステム。
- 不適切な使用技術は前記呼吸器薬剤デバイスの連続する使用の間の30秒以下を含む、請求項1から請求項5のいずれかに記載のシステム。
- 適切または不適切な使用技術の前記少なくとも1つの通知は、前記患者、介護者、およびヘルスプロバイダの少なくとも1人に電子的に提供される、請求項1から請求項6のいずれかに記載のシステム。
- ポータブルコンピューティングデバイスであるクライアントデバイスをさらに備え、前記クライアントデバイスは前記記憶デバイスおよび前記通信インターフェイスと通信している、請求項1から請求項7のいずれかに記載のシステム。
- 前記ポータブルコンピューティングデバイスはアプリケーションを含み、適切または不適切な使用技術の前記少なくとも1つの通知は、前記アプリケーションを介して提供される、請求項8に記載のシステム。
- 前記少なくとも1つの通知は不適切な使用技術を識別し、前記呼吸器薬剤デバイスの適切な使用技術に関するガイダンスを提供する、請求項1から請求項9のいずれかに記載のシステム。
- 前記ガイダンスは前記呼吸器薬剤デバイスの連続する使用の間の必要な前記時間期間を示すように構成されたタイマーを含む、請求項10に記載のシステム。
- 前記ガイダンスは前記呼吸器薬剤デバイスの適切な使用技術を確実にする前記必要な一連のステップを示す音声および/または視覚的コンテンツを含む、請求項10に記載のシステム。
- 前記少なくとも1つの通知は前記連続する使用を適切または不適切として分類した後、即時に、または所定のタイムスケジュールに従って遅延して提供される、請求項1から請求項12のいずれかに記載のシステム。
- 前記使用データは前記呼吸器薬剤デバイスに関連する薬剤センサによって検出される、請求項1から請求項13のいずれかに記載のシステム。
- 前記薬剤センサは前記呼吸器薬剤デバイスから脱着可能または前記呼吸器薬剤デバイスに統合されている、請求項14に記載のシステム。
- 呼吸器疾患に対する呼吸器薬剤デバイスの使用技術を決定するための方法であって、
患者の薬剤計画に関連する薬剤データを収集することと、
前記患者へコントローラまたはレスキュー呼吸薬剤を送出する呼吸器薬剤デバイスの使用データを収集することと、
記憶デバイスに前記薬剤データおよび前記使用データを送信することと、
前記記憶デバイスに前記薬剤データおよび前記使用データを格納することと、
前記収集された薬剤データに基づいて、薬剤デバイスのタイプが前記呼吸器薬剤デバイスの複数の連続する使用を必要とするかどうかを識別することと、
前記収集された使用データに基づいて、前記呼吸器薬剤デバイスの連続する使用の間のタイミングを決定することと、
前記呼吸器薬剤デバイスの連続する使用の間の前記タイミングに基づいて、適切または不適切な使用技術として前記連続する使用を分類し、使用技術の記録を生成することと、
前記使用技術の記録に基づく適切または不適切な使用技術の少なくとも1つの通知を提供し、適切な使用技術を確実にすることと、
を含む、方法。 - 呼吸器疾患に対する呼吸器薬剤デバイスの適切な使用技術を確実にするためのシステムであって、
患者の薬剤計画に関連する薬剤データを収集し、前記患者へコントローラまたはレスキュー呼吸薬剤を送出する呼吸器薬剤デバイスの使用データを収集する通信インターフェイスと、
前記収集された薬剤データを格納し、前記収集された使用データを格納する記憶デバイスと、
前記呼吸器薬剤デバイスの使用を示す収集された使用データに応答してガイダンスを提供する指示コンポーネントと、
前記収集された薬剤データに基づいて、使用中の薬剤デバイスが複数の連続する使用を必要とするかどうかを決定し、
前記収集された使用データに基づいて、前記呼吸器薬剤デバイスの第1の検出された使用を識別し、
前記呼吸器薬剤デバイスの前記第1の検出された使用に基づいて、前記指示コンポーネントを介してガイダンスを提供して、所定のタイムスケジュールに従って、前記呼吸器薬剤デバイスの第2の使用を指示する、
ように動作可能なデータ分析モジュールと、
を備えたシステム。 - 前記収集された薬剤データは、使用中の薬剤タイプ、使用中の薬剤デバイスタイプ、および所定の服用回数の少なくとも1つに関する情報を含む、請求項17に記載のシステム。
- 前記収集された薬剤データは、複数の薬剤タイプまたは薬剤デバイスタイプの連続する服用の間に必要な時間期間に関する情報を含む、請求項17または請求項18に記載のシステム。
- 前記所定のタイムスケジュールは、前記第1の検出された使用から30秒を超えた後、前記呼吸器薬剤デバイスの前記第2の使用を指示する、請求項17から請求項19のいずれかに記載のシステム。
- 前記使用データは、前記薬剤デバイスに関連付けられた薬剤センサによって検出される、請求項17から請求項20のいずれかに記載のシステム。
- 前記薬剤センサは前記呼吸器薬剤デバイスに取り付け可能である、または統合されるように構成されている、請求項22に記載のシステム。
- 前記システムはポータブルコンピューティングデバイスであるクライアントデバイスの一部を形成する、請求項17から請求項22のいずれかに記載のシステム。
- 前記指示コンポーネントは、前記ポータブルコンピューティングデバイスのアプリケーションの一部を形成する、請求項23に記載のシステム。
- 前記指示コンポーネントは前記呼吸器薬剤デバイスの前記第2の使用を指示するための音声および/または視覚コマンドを提供する、請求項17から請求項24のいずれかに記載のシステム。
- 前記音声および/または視覚コマンドは、前記所定のタイムスケジュールに設定されたタイマーを含む、請求項25に記載のシステム。
- 前記音声および/または視覚ガイダンスは、前記呼吸器薬剤デバイスの適切な使用技術を確実にする必要な一連のステップに関する指示を含む、請求項25または請求項26に記載のシステム。
- 呼吸器疾患に対する呼吸器薬剤デバイスの適切な使用技術を確実にするための方法であって、システムは、
患者の薬剤計画に関連する薬剤データを収集することと、
前記患者へコントローラまたはレスキュー呼吸薬剤を送出する呼吸器薬剤デバイスの使用データを収集することと、
記憶デバイスに、前記薬剤データおよび前記使用データを送信することと、
前記記憶デバイスに前記薬剤データおよび前記使用データを格納することと、
前記収集された薬剤データに基づいて、使用中の薬剤デバイスが複数の連続する使用を必要とするかどうかを決定することと、
前記収集された使用データに基づいて、前記呼吸器薬剤デバイスの第1の検出された使用を識別することと、
前記呼吸器薬剤デバイスの前記第1の検出された使用に基づいて、指示コンポーネントを介してガイダンスを提供して、所定のタイムスケジュールに従って、前記呼吸器薬剤デバイスの第2の使用を指示することと、
を備えた、方法。 - 呼吸器疾患に対する呼吸器薬剤デバイスの適切な使用技術を確実にするための薬剤センサであって、
患者へコントローラまたはレスキュー呼吸薬剤を送出する呼吸器薬剤デバイスの使用を検出する少なくとも1つのセンサと、
前記患者の薬剤計画に関連する薬剤データを格納し、前記呼吸器薬剤デバイスの前記検出された使用に関連する使用データを格納する、記憶デバイスと、
前記呼吸器薬剤デバイスの前記検出された使用に応答してガイダンスを提供する指示コンポーネントと、
前記薬剤データに基づいて、使用中の薬剤デバイスが複数の連続する使用を必要とするかどうかを決定し、
前記呼吸器薬剤デバイスの第1の検出された使用に基づいて、前記指示コンポーネントを介して、ガイダンスを提供して、所定のタイムスケジュールに従って、前記呼吸器薬剤デバイスの第2の使用を指示する、
ように動作可能なデータ分析モジュールと、
を備えた、薬剤センサ。 - 前記薬剤データは、使用中の薬剤タイプ、使用中の薬剤デバイスタイプ、および所定の服用回数の少なくとも1つに関する情報を含む、請求項29に記載の薬剤センサ。
- 前記薬剤データは、複数の薬剤タイプまたは薬剤デバイスタイプの連続する服用の間に必要な時間期間に関する情報を含む、請求項29または請求項30に記載の薬剤センサ。
- 前記所定のタイムスケジュールは、前記第1の検出された使用から30秒を超えた後、前記呼吸器薬剤デバイスの前記第2の使用を指示する、請求項29から請求項31のいずれかに記載の薬剤センサ。
- 前記薬剤センサは、モバイルコンピューティングデバイスと通信するためのワイヤレストランシーバをさらに含む、請求項29から請求項32のいずれかに記載の薬剤センサ。
- 前記指示コンポーネントは、前記呼吸器薬剤デバイスの前記第2の使用を指示するための音声および/または視覚ガイダンスを提供する、請求項29から請求項33のいずれかに記載の薬剤センサ。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962805934P | 2019-02-14 | 2019-02-14 | |
US62/805,934 | 2019-02-14 | ||
PCT/US2020/018198 WO2020168138A1 (en) | 2019-02-14 | 2020-02-13 | Systems and methods for improving respiratory medicament device usage |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022521722A true JP2022521722A (ja) | 2022-04-12 |
JPWO2020168138A5 JPWO2020168138A5 (ja) | 2023-01-11 |
Family
ID=72043872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021547876A Pending JP2022521722A (ja) | 2019-02-14 | 2020-02-13 | 呼吸器薬剤デバイスの使用を改善するためのシステムおよび方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220115107A1 (ja) |
EP (1) | EP3924976A4 (ja) |
JP (1) | JP2022521722A (ja) |
WO (1) | WO2020168138A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220115107A1 (en) * | 2019-02-14 | 2022-04-14 | Reciprocal Labs Corporation | Systems and Methods for Improving Respiratory Medicament Device Usage |
WO2024090835A1 (ko) * | 2022-10-25 | 2024-05-02 | 가톨릭대학교 산학협력단 | 가상 현실 기반의 정량식 흡입기 사용 훈련 서비스를 제공하기 위한 서버, 방법 및 시스템 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4283595A4 (en) * | 2021-01-28 | 2024-03-13 | Intin Inc | METHOD FOR GUIDING THE USE OF AN INHALER AND USER TERMINAL |
US11951246B1 (en) * | 2023-09-27 | 2024-04-09 | Yale University | Systems and methods for coaching inhaler use via synchronizing patient and respiratory cycle behaviors |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2384782A1 (en) * | 2000-11-30 | 2011-11-09 | Canon Kabushiki Kaisha | Portable terminal and health management method and system using portable terminal |
US9550031B2 (en) * | 2008-02-01 | 2017-01-24 | Reciprocal Labs Corporation | Device and method to monitor, track, map, and analyze usage of metered-dose inhalers in real-time |
JP2013517493A (ja) * | 2010-01-20 | 2013-05-16 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | フローセンサ及びエアロゾル送達装置 |
WO2011130583A2 (en) * | 2010-04-15 | 2011-10-20 | Spectrum Health Innovations, LLC | Inhaler module and related system |
WO2014004437A1 (en) * | 2012-06-25 | 2014-01-03 | Gecko Health Innovations, Inc. | Devices, systems, and methods for adherence monitoring and patient interaction |
EP3767632B1 (en) * | 2012-06-25 | 2024-05-29 | Gecko Health Innovations, Inc. | Devices, systems, and methods for adherence monitoring and patient interaction |
US8807131B1 (en) * | 2013-06-18 | 2014-08-19 | Isonea Limited | Compliance monitoring for asthma inhalers |
US10019555B2 (en) * | 2013-10-19 | 2018-07-10 | Cohero Health, Inc. | Interactive respiratory device usage tracking system |
CN112891688A (zh) * | 2014-08-28 | 2021-06-04 | 诺顿(沃特福特)有限公司 | 吸入器的依从性辅助模块 |
US10726954B2 (en) * | 2015-04-22 | 2020-07-28 | Reciprocal Labs Corporation | Predictive modeling of respiratory disease risk and events |
JP6987042B2 (ja) * | 2015-08-26 | 2021-12-22 | レスメッド センサー テクノロジーズ リミテッド | 慢性疾患の監視および管理のためのシステムおよび方法 |
US10957447B2 (en) * | 2015-10-15 | 2021-03-23 | Reciprocal Labs Corporation | Pre-emptive chronic obstructive pulmonary disease risk notifications based on medicament device monitoring |
US10255412B2 (en) * | 2015-11-13 | 2019-04-09 | Reciprocal Labs Corporation | Real time adaptive controller medication dosing |
JP2019516485A (ja) * | 2016-05-19 | 2019-06-20 | マンカインド コーポレイション | 吸入を検出および監視するための機器、システム、および方法 |
ES2929335T3 (es) * | 2016-05-27 | 2022-11-28 | Proveris Scient Corporation | Dispositivos para el uso de dispositivos de medicamento |
EP3375473A1 (en) * | 2017-03-17 | 2018-09-19 | PARI Pharma GmbH | Control device for aerosol nebulizer system |
US20210161213A1 (en) * | 2018-04-21 | 2021-06-03 | Gofire, Inc. | Smart vaporizer and system for concentrate products |
JP7423543B2 (ja) * | 2018-04-24 | 2024-01-29 | マンカインド コーポレイション | 吸入を検出し且つ監視するための装置、システム |
WO2019226576A1 (en) * | 2018-05-21 | 2019-11-28 | Reciprocal Labs Corporation (D/B/A Propeller Health) | Pre-emptive asthma risk notifications based on medicament device monitoring |
US20220115107A1 (en) * | 2019-02-14 | 2022-04-14 | Reciprocal Labs Corporation | Systems and Methods for Improving Respiratory Medicament Device Usage |
-
2020
- 2020-02-13 US US17/429,612 patent/US20220115107A1/en active Pending
- 2020-02-13 WO PCT/US2020/018198 patent/WO2020168138A1/en unknown
- 2020-02-13 EP EP20755879.2A patent/EP3924976A4/en active Pending
- 2020-02-13 JP JP2021547876A patent/JP2022521722A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220115107A1 (en) * | 2019-02-14 | 2022-04-14 | Reciprocal Labs Corporation | Systems and Methods for Improving Respiratory Medicament Device Usage |
WO2024090835A1 (ko) * | 2022-10-25 | 2024-05-02 | 가톨릭대학교 산학협력단 | 가상 현실 기반의 정량식 흡입기 사용 훈련 서비스를 제공하기 위한 서버, 방법 및 시스템 |
Also Published As
Publication number | Publication date |
---|---|
EP3924976A4 (en) | 2022-11-09 |
US20220115107A1 (en) | 2022-04-14 |
WO2020168138A1 (en) | 2020-08-20 |
EP3924976A1 (en) | 2021-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7471354B2 (ja) | 薬剤デバイス監視に基づくプリエンプティブな喘息リスク通知 | |
US11087867B2 (en) | Real time adaptive controller medication dosing | |
US20240145099A1 (en) | Evaluation of respiratory disease risk in a geographic region based on medicament device monitoring | |
JP2022521722A (ja) | 呼吸器薬剤デバイスの使用を改善するためのシステムおよび方法 | |
JP2021508112A (ja) | 患者呼吸器疾患データとのインタラクションのための動的グラフィカルユーザインターフェース | |
US11769598B2 (en) | Pre-emptive asthma risk notifications based on medicament device monitoring | |
US20180096104A1 (en) | Disease management system | |
US20220254499A1 (en) | Pre-Emptive Asthma Risk Notifications Based on Medicament Device Monitoring | |
Saglani et al. | How to manage a child with difficult asthma? | |
WO2022261125A1 (en) | Machine learning system and method to determine step up and step down of treatments | |
US20230178204A1 (en) | System and method to identify suitable patient subgroups for biologics | |
US20220375623A1 (en) | System and method for identification of asthma triggering conditions based on medicament device monitoring for a patent | |
WO2022256432A1 (en) | Mobile application for determining and recording medication | |
Koyuncu et al. | Filling the gaps in the evaluation and selection of mobile health technologies in respiratory medicine | |
JP2023545018A (ja) | 治療デバイス離脱の予測のためのシステム及び方法 | |
Kagwaini et al. | Factors influencing adherence to asthma control measures among patients in Mama Lucy Kibaki Hospital, Nairobi Kenya |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221227 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221227 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240109 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240405 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240507 |